CNS Stimulants: Amphetamines, Amphetamine Cogeners, Caffeine, Others

  • H. Thomas MilhornJr.

Abstract

The central nervous system stimulants include amphetamines, amphetamine cogeners, caffeine, methylphenidate, pemoline, phenylpropanolamine, cocaine, and nicotine (Table 12.1). Cocaine is discussed in Chapter 13, and nicotine in Chapter 14.

Keywords

Fatigue Obesity Nicotine Norepinephrine Theophylline 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    O’Brien, R., and S. Cohen.The Encyclopedia of Drug Abuse. Facts on File, New York, 1984.Google Scholar
  2. 2.
    Jaffe, J.H.Drug addiction and drug abuse. InGoodman and Gilman’s The Pharmacological Basis of Therapeutics. Ed. by A.G. Gilman, L.S. Goodman, T.W. Rail, and F. Murad. Macmillan, New York, 1985, pp. 537–581.Google Scholar
  3. 3.
    Wilford, B.B. (Ed.). Major drugs of abuse. InDrug Abuse: A Guide for the Primary Care Physician. American Medical Association, Chicago, 1981, pp. 21–84 Google Scholar
  4. 4.
    Shlafer, M., and E.N. Marieb. Substance use and misuse. InThe Nurse, Pharmacology, and Drug Therapy. Addison-Wesley, Red Wood City, California, 1989, pp. 509–528.Google Scholar
  5. 5.
    Weiner, N. Norepinephrine, epinephrine, and the sympathomimetic amines. InGoodman and Gilman’s The Pharmacological Basis of Therapeutics. Ed. by A.G. Gilman, L.S. Goodman, T.W. Rail, and F. Murad. Macmillan, New York, 1985, pp. 145–180.Google Scholar
  6. 6.
    Jackson, J.G. Hazards of smokable methamphetamine.New England Journal of Medicine, 321:907, 1989.PubMedGoogle Scholar
  7. 7.
    Halle, A.B., R. Kessler, and M. Alvarez. Drug abuse with Vicks Nasal Inhaler.Southern Medical Journal, 78:761–762, 1985.PubMedCrossRefGoogle Scholar
  8. 8.
    Schuckit, M.A. Caffeine: The most widely used drug.Vista Hill Foundation Drug Abuse and Alcoholism Newsletter, vol. 18, May, 1989.Google Scholar
  9. 9.
    Clementz, G.L., and J.D. Dailey. Psychotropic effects of caffeine.American Family Physician, 37:167–172, 1988.PubMedGoogle Scholar
  10. 10.
    Franz, D.N. Central nervous system stimulants. InGoodman and Gilman’s The Pharmacological Basis of Therapeutics. Ed. by A.G. Gilman, L.S. Goodman, T.W. Rail, and F. Murad. Macmillan, New York, 1985, pp. 587–588.Google Scholar
  11. 11.
    Dilsaner, S.C., N.A. Votolato, and N.E. Alessi. Complications of phenylpropanolamine.American Family Physician, 39:201–206, 1989.Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1990

Authors and Affiliations

  • H. Thomas MilhornJr.
    • 1
  1. 1.Department of Family MedicineUniversity of Mississippi Medical CenterMississippiUSA

Personalised recommendations